12 June
2024
Advanced Medical Solutions Group
plc
("AMS" or
the "Group")
Annual General Meeting
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the world-leading specialist in tissue-healing
technologies, will
hold its Annual General Meeting at 11.00 am today at the offices of
Investec Bank plc, 30 Gresham Street, London, EC2V 7QP.
Chris Meredith, AMS's Chief
Executive Officer, will give a short presentation at the Annual
General Meeting. No new material information will be
provided.
The results of the AGM will be
announced to the London Stock Exchange and placed on the Group's
website, in the usual way, as soon as practicable after the
conclusion of the AGM.
- End -
For
further information, please visit www.admedsol.com
or
contact:
Advanced Medical Solutions Group plc
|
Tel: +44
(0) 1606 545508
|
Chris Meredith, Chief Executive
Officer
Eddie Johnson, Chief Financial
Officer
Michael King, Investor
Relations
|
|
|
|
ICR
Consilium
|
Tel: +44
(0) 20 3709 5700
|
Mary-Jane Elliott
/ Lucy Featherstone
|
AMS@icrhealthcare.com
|
|
|
Investec Bank PLC (NOMAD & Broker)
|
Tel: +44
(0) 20 7597 5970
|
Gary Clarence / David
Anderson
|
|
HSBC Bank plc (Broker)
|
Tel: 44
(0) 20 7991 8888
|
Sam McLennan / Joe Weaving /
Stephanie Cornish
|
|
About Advanced Medical Solutions Group plc
-
see www.admedsol.com
AMS is a world-leading independent
developer and manufacturer of innovative tissue-healing technology,
focused on quality outcomes for patients and value for payers. AMS
has a wide range of surgical products including tissue adhesives,
sutures, haemostats, internal fixation devices and internal
sealants, which it markets under its brands LiquiBand®,
RESORBA®, LiquiBandFix8® and
Seal-G®. AMS also supplies wound care dressings such as
silver alginates, alginates and foams through its
ActivHeal® brand as well as under white label.
Since 2019, the Group has made six acquisitions: Sealantis, an
Israeli developer of innovative internal sealants; Biomatlante, a
French developer and manufacturer of surgical biomaterials,
Raleigh, a leading UK coater and converter of woundcare and
bio-diagnostics materials, AFS Medical, an Austrian specialist
surgical business, Connexicon, an Irish tissue adhesives
specialist, and Syntacoll, a German
specialist in collagen-based absorbable surgical
implants.
AMS's products, manufactured in the
UK, Germany, France, the Netherlands, the Czech Republic and
Israel, are sold globally via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia. The
Group has R&D innovation hubs in the UK, Ireland, Germany,
France and Israel. Established in 1991, the Group has more than 900
employees. For more information, please see www.admedsol.com.